Tuberous sclerosis, also called tuberous sclerosis complex (TSC), is a rare genetic multisystem disorder characterized by the ...

Agios Pharma submitted a sNDA to the FDA after two Phase III trials studying PYRUKYND (mitapivat) in thalassemia met their ...

Asia Pacific Leads Next Wave of Sickle Cell Screening Adoption as Public Health Funding Expands Global Sickle Cell Anemia ...

The Gates Foundation will invest up to $50 million to support Tessera's SCD gene editing treatment, the company said.

More than 500,000 babies were tested for sickle cell disease in Catalonia’s newborn screening program, with 160 cases ...

Gene-editing kicked off 2024 with a bang in the medical sector but closed the year with a whimper. It started with the FDA ...

Sickle Cell Disease (SCD) is an inherited genetic condition that causes red blood cells to assume a rigid, crescent-like shape. These malformed cells obstruct blood vessels, leading to severe pain and ...

Researchers at the CSIR-CCMB, Hyderabad developed a rapid test identifying sickle cell anaemia -- a group of inherited blood disorders. The test is an accurate, rapid, and affordable molecular ...

The initiative aims to identify molecular features specific to Indian breast cancer cases, which could enhance clinical management and treatment options. Researchers at the CSIR-CCMB, Hyderabad ...